Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures [Phase 3]

View source ↗

Summary

Efficacy and safety results from a Phase 3 trial evaluating eslicarbazepine acetate as monotherapy in adults with newly diagnosed partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED